Otsuka Holdings Co OTSKY Stock Profile

Description: Otsuka Holdings Co., Ltd., through its subsidiaries, operates in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of central nervous system disorders, oncology, cardiovascular-renal, infectious disease, dermatological disease, gastroenterology, ophthalmology, diagnostics, surgical aid and regenerative, allergy/immunology, and urology. It also provides EQUELLE, a food product for women's health; BODYMAINTÉ Jelly, a conditioning food product; POCARI SWEAT, an electrolyte drink; Calorie Mate, a nutritional food product; SOYJOY, a soy bar; OS-1, an oral rehydration solution; HINE E-GEL, a concentrated liquid diet; PROCESSLEAD, a chew and swallow managing food product; REHADAYS, a beverage to support exercise and rehabilitation; Oronine H Ointment, a household antiseptic medicine; and vitamin tonics, herbal digestive drinks, and herbal crude drugs. In addition, the company offers soft drinks, foods, and wines; chemical materials for automotive, electrical, electronic, and building materials sectors; electronic equipment; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards and board arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; business information consultancy services; caps and ports for containers; and hydrazine. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.

Keywords: Building Materials Pharmaceutical Beverage Pharmaceutical Products Consumer Products Immunology Paper Products Electronic Equipment Ceramic Nutraceutical Ophthalmology Allergy Potassium Mental Health Urology Transport Services Industrial Chemical Polyol Pharmaceutical Intermediates Chemical Materials Gastroenterology Central Nervous System Disorders Measurement Equipment Exercise Polyolefin Healthcare System Business Information Hydration Mineral Water Foams Tonics Electrolyte Otsuka Pharmaceutical Nutritional Food Septic Oral Rehydration Quell Dermatological Disease Nutritional Food Product Oral Rehydration Solution Pocari Sweat Rehydration Business Information Consultancy Services Cardiovascular Renal Food Product Mental Healthcare Systems Synthetic Resin Molded Products

Home Page: www.otsuka.com

2-9 Kanda-Tsukasamachi
Tokyo, 101-0048
Japan
Phone: 81 3 6717 1410

Officers

Name	Title
Mr. Tatsuo Higuchi	CEO, Pres & Representative Director
Ms. Noriko Tojo	Exec. Director
Mr. Yoshiro Matsuo	Exec. Deputy Pres & Director
Mr. Masayuki Kobayashi	Exec. Director
Mr. Makoto Inoue	Exec. Director
Ms. Yuko Makino	CFO & Exec. Director
Tsuyoshi Nakamura	VP and Head of Fin. & Accounting
Akiko Ryu	Sr. VP & Director of Human Resource Planning Department
Mr. Shuichi Takagi	MD, CSO & Director
Chiaki Sakurai	Sr. VP of Nutraceutical Bus., Global Strategy & Planning Headquarters

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)

Forward PE:	15.3374
Trailing PE:	19.961
Price-to-Book MRQ:	1.1021
Price-to-Sales TTM:	0.0109
IPO Date:
Fiscal Year End:	December
Full Time Employees:	33226

Otsuka Holdings Co(OTSKY)